txome.ai, an AI-driven transcriptome analysis and biomarker discovery platform

Transcriptome analysis

Hyperscale platform providing advanced transcriptome analysis, identification of novel targets and generation of multidimensional biomarkers

Detailed Expression-based Analysis

Expression clustering, principal component analysis (PCA) and high variance gene identification

Multiple Machine Learning Models

Multiple machine learning models to predict the labels of interest and provide a variety of performance measures for prediction and cross-validation

Immune Cell Deconvolution

Estimate the fractions of immune cells from bulk gene expression profiles of tissues

Functional Profiling

Meaningful interpretation of differential gene expression using gene set enrichment analysis on GO databases and pathway analysis 

Cutting-edge Structural Variant (TSV) Detection

Their translational impact, TSV type, ancestry-specific filtering, coverage anomaly detection, informative visualizations, and the location of breakpoints. LEARN MORE >

Novel Transcript Detection

Find transcripts that are not present in the reference and extends the reference. Mapping information is provided to the new reference along with expression information with the new transcripts

Alternative Splicing and Percent Spliced in

Detects possible alternative splicing events and calculates percent sliced in for each of the events 

Multiple Differential Analysis

Differential gene expression, differential transcript expression, and differential transcript usage 

Rigorous Quality Control

Trims reads to increase the Q30 rate, corrects for biases, detects unwanted contamination, and provides detailed insights on the bias distribution

Ultrafast and Highly Accurate Mapping

Provides accurate quantification fast and detailed mapping statistics like the number of dovetail, concordant, and compact fragments

Interested in discussing how we can help in your drug development or biomarker programs and studies?

Ocean Genomics provides essential capabilities and its txome.ai platform to discover targets and biomarkers and understand effects on gene-expression and biology.

Please complete the form and we will contact you shortly, or email us directly at contact@oceangenomics.com

Samsung Medical Center partners with Ocean Genomics to find novel drug targets in ICI-resistant Gatric Cancer

The abstract, “Novel target discovery in immunotherapy-resistant gastric cancer using a comprehensive RNA-seq analysis pipeline” was shared at ASCO’s annual meeting. Read more about the methods, results, and conclusions of the study.